BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 9143708)

  • 1. Capture and processing of exogenous antigens for presentation on MHC molecules.
    Watts C
    Annu Rev Immunol; 1997; 15():821-50. PubMed ID: 9143708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell biology of antigen processing and presentation.
    Brodsky FM; Guagliardi LE
    Annu Rev Immunol; 1991; 9():707-44. PubMed ID: 1910692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules.
    Harding CV
    Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes.
    Harding CV; Song R; Griffin J; France J; Wick MJ; Pfeifer JD; Geuze HJ
    Infect Agents Dis; 1995 Mar; 4(1):1-12. PubMed ID: 7728352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
    Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
    Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis.
    Engering A; Lefkovits I; Pieters J
    Electrophoresis; 1997 Dec; 18(14):2523-30. PubMed ID: 9527480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation and T cell stimulation by dendritic cells.
    Guermonprez P; Valladeau J; Zitvogel L; Théry C; Amigorena S
    Annu Rev Immunol; 2002; 20():621-67. PubMed ID: 11861614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
    Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
    Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface.
    Pond L; Watts C
    J Immunol; 1997 Jul; 159(2):543-53. PubMed ID: 9218568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.
    Hari A; Ganguly A; Mu L; Davis SP; Stenner MD; Lam R; Munro F; Namet I; Alghamdi E; Fürstenhaupt T; Dong W; Detampel P; Shen LJ; Amrein MW; Yates RM; Shi Y
    Eur J Immunol; 2015 Feb; 45(2):383-95. PubMed ID: 25378230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
    Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation.
    Delamarre L; Holcombe H; Mellman I
    J Exp Med; 2003 Jul; 198(1):111-22. PubMed ID: 12835477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.